It looks like nothing was found at this location. Maybe try one of the links below or a search?
Popular Articles:
-
Response to EPO consultation: Don’t impose oral proceedings by videoconference
-
Quality at the EPO – One Modest and one Serious Proposal
-
‘Opposition against Unitary Patent comes from fearful lawyers and critics who only have a theoretical interest’
-
Leading German patent law firms criticize European Patent Office
-
UPC: four reasons on why the PPA is not legally in force
-
The EPO’s Vision (V) – Trust
Recent Articles:
-
Announcement of the national program “MOVER” raises expectations for an increase in patent filings for green technology
-
UPC “saisie-contrefaçon” Part III: the “C-Kore” case
-
Brazil: Animal Health and Patent Litigation
-
China’s Supreme People Court decides FRAND dispute in ACT v Oppo
-
UPC “saisie-contrefaçon” Part II: the “OERLIKON” case
-
UPC “saisie-contrefaçon” Part I: the texts
Random Articles:
-
Swiss-Form Claims, Skinny Labelling and the duty of the National Health Service – the Lyrica case continues
-
Top 3 Posts of the Autumn from our IP Law Blogs
-
Pfizer ordered to pay Euro 10.6 million for abuse of dominant position by the Italian Antitrust Authority
-
Imperceptibly different image/HOURPLACE, European Patent Office (EPO Board of Appeal), 30 September 2009
-
Treatment by surgery, European Patent Office (EPO Enlarged Board of Appeal), 15 February 2010
-
Why not take the shortcut? The Swiss Supreme Court’s assessment of patent infringement under the doctrine of equivalence
-
Pharmachemie v. Glaxo Group, Supreme Court (Hoge Raad), 22 June 2012
-
The tension between competition law and IP rights in China: What IP rights holders should know
-
BREAKING: The EPO is able to listen
-
Do American Indian Tribal Deals Shield Patent Owners from Inter Partes Review?